162 results
SC 14D9
CTIC
CTI BioPharma Corp
25 May 23
Tender offer solicitation
7:00am
of approximately $3.55 to $7.43 per Share.
Analyst Price Target Analysis. Centerview reviewed stock price targets for the Shares in publicly available Wall … Street research analyst reports, which indicated low and high stock price targets for CTI ranging from $8.00 to $15.00 per Share.
Precedent Premiums
SC TO-C
EX-99.2
CTIC
CTI BioPharma Corp
10 May 23
Information about tender offer
5:01pm
restrictions and clean safety profile First and only JAK1-sparing inhibitor that targets both JAK2 and IRAK11 Safe and efficacious CD-19 ADC in severe … ., NEJM, 2010
VONJO is the first and only JAK1-sparing inhibitor that targets both JAK2 and IRAK1 Ref. CTI Company investor presentation; 1. Jarocha J, et
424B5
plli1nem zpk
14 Feb 20
Prospectus supplement for primary offering
8:14am